Treatment of complicated infantile hemangiomas* with oral propranolol
Treatment of complicated infantile hemangiomas* with oral propranolol
ECG: electrocardiogram; MRI: magnetic resonance imaging; PHACE: posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities; bpm: beats per minute. * Complicated hemangiomas include:
Large hemangiomas at increased risk of scarring or disfigurement
Life-threatening hemangiomas
Hemangiomas carrying functional risks
Ulcerated hemangiomas
¶ Postnatal age in weeks minus number of weeks preterm. Δ Falsely low or high blood pressure measurements may occur if an inappropriate cuff size is used. In addition, the infant's behavioral state (crying/agitated versus calm/sleeping) can greatly impact blood pressure measurements. Refer to UpToDate topics on measurement of blood pressure in infants and children. ◊ Baseline head/neck MRI with angiography is also preferred in infants with large facial hemangiomas at risk for PHACE prior to initiating propranolol; however, in infants needing urgent treatment, propranolol may be given in the wait for neuroimaging results. Propranolol can be initiated at a lower dose and slowly titrated up to a maximum dose of 1 mg/kg/day. § This is a suggested initial dose; however, the initial dose and titration may vary according to local protocols. ¥ Serious adverse reactions:
Bradycardia (<90 bpm in newborns and infants ≤3 months)
Hypotension
Bronchospasm
Hypoglycemia
Refer to UpToDate topics on beta-blocker toxicity. ‡ Early signs of hypoglycemia:
Sweating (most important, not masked by beta blockers)
Jitteriness
Irritability
Cyanosis
Poor feeding
Hypothermia
Lethargy
Refer to UpToDate topics on hypoglycemia in infancy.
Graphic 109423 Version 1.0
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟